Your SlideShare is downloading. ×
Post myocardial infarction – pipeline review, h1 2012
Post myocardial infarction – pipeline review, h1 2012
Post myocardial infarction – pipeline review, h1 2012
Post myocardial infarction – pipeline review, h1 2012
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Post myocardial infarction – pipeline review, h1 2012

145

Published on

Aarkstore.com || Post-Myocardial Infarction – Pipeline Review, H1 2012 || Market Research latest report

Aarkstore.com || Post-Myocardial Infarction – Pipeline Review, H1 2012 || Market Research latest report

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
145
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Aarkstore.com announces, The Latest market research report is available inits vast collection:Post-Myocardial Infarction – Pipeline Review, H1 2012You can also request for sample page of above mention reports onsample@aarkstore.comSummaryGlobal Markets Direct’s, Post-Myocardial Infarction - Pipeline Review, H1 2012,provides an overview of the Post-Myocardial Infarction therapeutic pipeline. Thisreport provides information on the therapeutic development for Post-MyocardialInfarction, complete with latest updates, and special features on late-stage anddiscontinued projects. It also reviews key players involved in the therapeuticdevelopment for Post-Myocardial Infarction. Post-Myocardial Infarction - PipelineReview, H1 2012 is built using data and information sourced from Global MarketsDirect’s proprietary databases, Company/University websites, SEC filings, investorpresentations and featured press releases from company/university sites andindustry-specific third party sources, put together by Global Markets Direct’s team.Note*: Certain sections in the report may be removed or altered based on theavailability and relevance of data for the indicated disease.Scope- A snapshot of the global therapeutic scenario for Post-Myocardial Infarction.- A review of the Post-Myocardial Infarction products under development bycompanies and universities/research institutes based on information derived fromcompany and industry-specific sources.- Coverage of products based on various stages of development ranging fromdiscovery till registration stages.- A feature on pipeline projects on the basis of monotherapy and combined
  • 2. therapeutics.Table of contents:List of Tables 3List of Figures 3Introduction 4Global Markets Direct Report Coverage 4Post-Myocardial Infarction Overview 5Therapeutics Development 6An Overview of Pipeline Products for Post-Myocardial Infarction 6Post-Myocardial Infarction Therapeutics under Development by Companies 8Post-Myocardial Infarction Therapeutics under Investigation byUniversities/Institutes 9Mid Clinical Stage Products 10Comparative Analysis 10Pre-Clinical Stage Products 11Comparative Analysis 11Post-Myocardial Infarction Therapeutics – Products under Development byCompanies 12Post-Myocardial Infarction Therapeutics – Products under Investigation byUniversities/Institutes 13Companies Involved in Post-Myocardial Infarction Therapeutics Development 14miRagen Therapeutics, Inc. 14Post-Myocardial Infarction – Therapeutics Assessment 15Assessment by Monotherapy Products 15Assessment by Molecule Type 16Drug Profiles 18Natrecor - Drug Profile 18Product Description 18Mechanism of Action 18R&D Progress 18MGN-1374 - Drug Profile 19Product Description 19Mechanism of Action 19R&D Progress 19
  • 3. Post-Myocardial Infarction Therapeutics – Drug Profile Updates 20Post-Myocardial Infarction – Product Development Milestones 21List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Pipeline Review, H1 2012http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H12012&PubId=&pagenum=1Refractory Angina – Pipeline Review, H1 2012Post-Myocardial Infarction – Pipeline Review, H1 2012Proteinuria – Pipeline Review, H1 2012Ocular Pain – Pipeline Review, H1 2012Pediculosis (Head Lice Infestation) – Pipeline Review, H1 2012Allergic Rhino-Conjunctivitis – Pipeline Review, H1 2012Acquired (Autoimmune) Hemolytic Anemia – Pipeline Review, H1 2012Thyroid Gland Disorders – Pipeline Review, H1 2012
  • 4. Tinea Corporis – Pipeline Review, H1 2012Pulmonary Fibrosis – Pipeline Review, H1 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcarehttp://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: enquiry@aarkstore.com

×